MSSTF
Price:
$0.53807
Market Cap:
$74.96M
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Industry
Biotechnology
IPO Date
2021-02-08
Stock Exchange
OTC
Ticker
MSSTF
According to Mindset Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -13.45. This represents a change of 20.64% compared to the average of -11.15 of the last 4 quarters.
The mean historical PE Ratio of Mindset Pharma Inc. over the last ten years is -1686.25. The current -13.45 PE Ratio has changed -20.23% with respect to the historical average. Over the past ten years (40 quarters), MSSTF's PE Ratio was at its highest in in the June 2019 quarter at 56.05K. The PE Ratio was at its lowest in in the March 2020 quarter at -879.16.
Average
-1686.25
Median
-1000.16
Minimum
-4742.64
Maximum
-2.06
Discovering the peaks and valleys of Mindset Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -2.06
Minimum Annual Increase = -99.89%
Minimum Annual PE Ratio = -4742.64
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -2.06 | -7.46% |
| 2021 | -2.23 | -99.89% |
| 2019 | -1998.09 | -57.87% |
The current PE Ratio of Mindset Pharma Inc. (MSSTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-667.46
5-year avg
-1686.25
10-year avg
-1686.25
Mindset Pharma Inc.’s PE Ratio is less than Oncopeptides AB (publ) (-4.54), less than Biostage, Inc. (-9.60), less than Herantis Pharma Oyj (-9.37), less than Medivir AB (publ) (-4.51), greater than Healthcare Integrated Technologies, Inc. (-14.49), less than Abliva AB (publ) (-9.56), less than Relief Therapeutics Holding AG (-2.06), less than MCI Onehealth Technologies Inc. (0), greater than INNOCAN PHARMA Corp (-20.39), less than Karolinska Development AB (publ) (-0.68),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.54 | $55.98M | |
| -9.60 | $57.82M | |
| -9.37 | $59.47M | |
| -4.51 | $45.78M | |
| -14.49 | $52.84M | |
| -9.56 | $45.13M | |
| -2.06 | $44.94M | |
| 0 | $54.04M | |
| -20.39 | $30.86M | |
| -0.68 | $68.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mindset Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mindset Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mindset Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Mindset Pharma Inc. (MSSTF)?
What is the highest PE Ratio for Mindset Pharma Inc. (MSSTF)?
What is the 3-year average PE Ratio for Mindset Pharma Inc. (MSSTF)?
What is the 5-year average PE Ratio for Mindset Pharma Inc. (MSSTF)?
How does the current PE Ratio for Mindset Pharma Inc. (MSSTF) compare to its historical average?